FDA clears iHealthScreen’s AI diabetic retinopathy screening software

The company's software analyses images captured by the iCare DRSplus camera, a tool widely used in ophthalmology clinics and optician shops across the US. The company's software analyses images captured by the iCare DRSplus camera, a tool widely used in ophthalmology clinics and optician shops across the US. Diabetic retinopathy is a leading cause of preventable blindness worldwide. Credit: Poetra.RH / Shutterstock.com Software as a Medical Device (SaMD) developer iHealthScreen has obtained US Food and Drug Administration (FDA) clearance for iPredict-DR, an artificial intelligence (AI)-based screening software for diabetic retinopathy. The software uses AI to detect ‘more than mild’ diabetic…

Source: Medical Device Network